Biosensis MAP2 antibodies

Friday, 05 April, 2024 | Supplied by: Sapphire Bioscience


Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.

The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Cytek Tonbo Mouse TBNK/Myeloid/Treg Kit

The kit has been designed to enable researchers to quickly perform basic immunophenotyping and...

FUJIFILM Irvine Scientific Shenandoah Cytokines

FUJIFILM Irvine Scientific provides recombinant cytokines to the academic and industrial...

Cayman Chemical Natural Products Screening Library

Cayman Chemical's Natural Products Screening Library consists of 22 plates and contains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd